Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “asthma”
- A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaActive Not Recruiting
Sponsor: Amgen
Asthma
United States, Australia, Belgium, Canada, United Kingdom
Sponsor: Helsinki University Central Hospital
Severe Asthma · Asthma
Finland
- Infant RSV Immunity StudyRecruiting
Sponsor: University of British Columbia
Respiratory Synctial Virus · Asthma Childhood
Canada
- THERMotherapy Against Persistent Bacterial LUNG InfectionsNot Yet Recruiting
Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Lung Diseases, Obstructive · Bronchiectasis · Asthma · Copd
Denmark
Sponsor: GlaxoSmithKline
Asthma
United States
- Scaling up the Integrated Care Pathway for Acute Asthma to All Osakidetza Pediatric Services Through a Cluster-randomized SMART DesignNot Yet Recruiting
Sponsor: Basque Health Service
Asthma in Children
Spain
Sponsor: University of Petra
Hypertension · Diabetes Mellitus · Dyslipidemias · Cardiovascular Diseases
Jordan
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.Active Not Recruiting
Sponsor: AstraZeneca
Severe Asthma
United States, Argentina, Belgium, Bulgaria, Canada +7 more
Sponsor: University Hospitals, Leicester
Chronic Obstructive Pulmonary Disease (COPD) · Asthma (Diagnosis) · Interstitial Lung Disease (ILD) · Bronchiectasis
United Kingdom
Sponsor: Jemincare
Allergic Asthma
China
Sponsor: University Hospital, Montpellier
Asthma
France
- EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in GreeceActive Not Recruiting
Sponsor: AstraZeneca
Asthma
Greece
- Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)Active Not Recruiting
Sponsor: AstraZeneca
Severe Asthma
Israel
Sponsor: Queen Mary University of London
Asthma Acute · Respiratory
United Kingdom
Sponsor: University Hospital, Montpellier
Asthma
France
Sponsor: AstraZeneca
Asthma
United States
- A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)Not Yet Recruiting
Sponsor: GlaxoSmithKline
Asthma
Sponsor: Erin M Rodriguez
Asthma in Children
United States
- Active Airways for Children and Young People With AsthmaNot Yet Recruiting
Sponsor: University of Leicester
Asthma Childhood · Exercise · Children
United Kingdom
Sponsor: University of California, San Francisco
Asthma
United States
Sponsor: AstraZeneca
Bronchial Asthma
Japan
Sponsor: AstraZeneca
Bronchial Asthma
Japan
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Asthma
China
- Use of Dupilumab in Asthma in Real-world SettingActive Not Recruiting
Sponsor: Hospices Civils de Lyon
Asthma Acute
France
Sponsor: Naestved Hospital
Dysfunctional Breathing in Asthma
Denmark